Nevertheless, we suggest that the safety of scAAV8-MCK-TNALP-D10 gene therapy gives it potential for not only prolonging survival and growth, but also for the formation of acellular cementum, dentin, and alveolar bone in patients with lethal HPP, although some of the risks of tooth exfoliation would remain. Here, ALPL is linked to hypophosphatasia.